Non-modifiable risk factors include gender (females face a heightened risk of BC development, with men accounting for only 0.5–1% of cases), age (with a higher incidence in those over 40 years), family history of BC, and genetic mutations in the BRCA1, BRCA2, and PALB-2 genes. This evidence concerns the gene BRCA1 and breast cancer.